SCHEMBL218665

SCHEMBL218665

CON(C)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL10782731 0.94
SCHEMBL6162650 0.77
SCHEMBL2575938 0.73 MEN1 (0.35)
Methoxymethane SCHEMBL1883896 0.73
SCHEMBL3624066 0.73 MEN1 (0.35)
SCHEMBL6138263 0.71
SCHEMBL218587 0.71
SCHEMBL8893309 0.71
SCHEMBL4398581 0.71
SCHEMBL29737040 0.71 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4493546-B1 IMIDAZOLE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2026-05-06 EP claimed
EP-4493546-A1 IMIDAZOLE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2025-01-22 EP claimed
CN-119278197-A Imidazole derivatives as potassium channel inhibitors 阿塞西翁制药公司 2025-01-07 CN claimed
WO-2023174836-A1 IMIDAZOLE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2023-09-21 WO claimed
CN-109154776-A Chemical amplifying type negative photoresist composition 荣昌化学制品株式会社 2019-01-04 CN claimed
CN-109073973-A KrF laser negative photoresist composition with high-resolution and high aspect ratio 荣昌化学制品株式会社 2018-12-21 CN claimed
US-20170100352-A1 Methods for treating or preventing neuroinflammation or autoimmune diseases ELFORD HOWARD L (US) 2017-04-13 US claimed
US-20150024436-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC, (US) 2015-01-22 US claimed
EP-2030615-A2 Ribonucleotide reductase inhibitors for use in the treatment or prevention of neuroinflammatory or autoimmune diseases ELFORD, Howard L. (US) 2009-03-04 EP claimed
US-20090047250-A1 Methods for treating or preventing neuroinflammation or autoimmune diseases ELFORD HOWARD L 2009-02-19 US claimed
US-20250171841-A1 SAMPLE PREPARATION, PROCESSING AND ANALYSIS SYSTEMS INTEGENX INC. (US) 2025-05-29 US disclosed
US-20250128993-A1 AGRICULTURAL ADJUVANT COMPRISING MICROFIBRILLATED CELLULOSE AMVAC CHEMICAL CORPORATION 2025-04-24 US disclosed
EP-4493546-A1 IMIDAZOLE DERIVATIVES AS POTASSIUM CHANNEL INHIBITORS ACESION PHARMA APS (DK) 2025-01-22 EP disclosed
CN-119278197-A Imidazole derivatives as potassium channel inhibitors 阿塞西翁制药公司 2025-01-07 CN disclosed
US-12168798-B2 Sample preparation, processing and analysis systems INTEGENX. INC. (US) 2024-12-17 US disclosed
US-4263219-A METHYLATION IN TWO-PHASE REACTION MEDIUM SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1981-04-21 US disclosed
EP-0003835-A1 A hydroxy-urea, process for producing the same and a process for producing a phenyl-substituted N-methoxy-N-methyl-urea SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-09-05 EP disclosed
EP-0003835-A1 A hydroxy-urea, process for producing the same and a process for producing a phenyl-substituted N-methoxy-N-methyl-urea SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-09-05 EP disclosed
US-4105613-A CORROSION RESISTANCE THE DEXTER CORPORATION (US) 1978-08-08 US disclosed
US-4076540-A IONIC COMPLEX, BORIC ACID COMPOUND, UREA STOSSEL ERNEST 1978-02-28 US disclosed